Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.35 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Xanthone derivatives have shown promising antitumor properties, and 1-carbaldehyde-3,4-
dimethoxyxanthone (1) has recently emerged as a potent tumor cell growth inhibitor. In this study, its
effect was evaluated (MTT viability assay) against a new panel of cancer cells, namely cervical cancer
(HeLa), androgen-sensitive (LNCaP) and androgen-independent (PC-3) prostate cancer, and nonsolid
tumor derived cancer (Jurkat) cell lines. The effect of xanthone 1 on macrophage functions was also
evaluated. The effect of xanthone 1-conditioned THP-1 human macrophage supernatants on the
metabolic viability of cervical and prostate cancer cell lines was determined along with its interference
with cytokine expression characteristic of M1 profile (IL-1 ≤ β; TNF-α) or M2 profile (IL-10; TGF-β)
(PCR and ELISA). Nitric oxide (NO) production by murine RAW264.7 macrophages was quantified
by Griess reaction. Xanthone 1 (20 µM) strongly inhibited the metabolic activity of the cell lines and
was significantly more active against prostate cell lines compared to HeLa (p < 0.05). Jurkat was
the cell most sensitive to the effect of xanthone 1. Compound 1-conditioned IL-4-stimulated THP-1
macrophage supernatants significantly (p < 0.05) inhibited the metabolic activity of HeLa, LNCaP,
and PC-3. Xanthone 1 did not significantly affect the expression of cytokines by THP-1 macrophages.
The inhibiting effect of compound 1 observed on the production of NO by RAW 264.7 macrophages
was moderate. In conclusion, 1-carbaldehyde-3,4-dimethoxyxanthone (1) decreases the metabolic
activity of cancer cells and seems to be able to modulate macrophage functions.
Description
Keywords
1-carbaldehyde-3,4-dimethoxyxanthone Antitumor Prostate cancer Cervical cancer Immunomodulation Macrophage function Cytokines
Citation
Publisher
MDPI